Compare EXK & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXK | ITGR |
|---|---|---|
| Founded | 1981 | 1970 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.4B |
| IPO Year | N/A | 2000 |
| Metric | EXK | ITGR |
|---|---|---|
| Price | $9.53 | $72.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $11.69 | ★ $92.86 |
| AVG Volume (30 Days) | ★ 13.5M | 594.7K |
| Earning Date | 11-07-2025 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.42 |
| Revenue | $337,137,000.00 | ★ $1,831,074,000.00 |
| Revenue This Year | $111.57 | $9.58 |
| Revenue Next Year | $64.09 | N/A |
| P/E Ratio | ★ N/A | $29.67 |
| Revenue Growth | ★ 49.22 | 9.54 |
| 52 Week Low | $2.95 | $62.00 |
| 52 Week High | $10.37 | $146.36 |
| Indicator | EXK | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 62.94 | 50.17 |
| Support Level | $8.30 | $69.12 |
| Resistance Level | $9.13 | $71.49 |
| Average True Range (ATR) | 0.62 | 1.67 |
| MACD | 0.08 | 1.08 |
| Stochastic Oscillator | 84.78 | 87.38 |
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.